The Journal of Current Oncology is an open access, peer reviewed journal that aims to highlight the advances in Cancer Biology and management through an optimal mix of review articles, original research, case reports, letter to editors, resident pages and vignettes from frontline research. It shall provide its contributors the benefit of review of their work by renowned experts and its reader with the authentic, well researched and reviewed information on all aspects of cancer.
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
- To provide contemporary information in Oncology.
- To highlight diverse spheres of Research in Oncology.
- To provide young and experience scientists / clinicians a platform to publish their research in a peer reviewed open access journal for a worldwide readership.
- To deliver solutions to multifaceted problems confronted routinely in the practice of oncology from screening to survivorship.
The Journal intends to cover all aspects of cancer biology, research, therapeutics and prevention. Some cancer therapies are also shifting from a tissue-specific focus to an oncogenetic pathway specific one. Developments in these new paradigms have a long way to go and it is a critical time for the field. Both patient volume and research in this field are increasing rapidly as are diagnostic and prognostic tests, targeted treatments and new practice patterns. It aspires to keep its readers abreast with high quality research work, scientific innovation, clinical Practice and surgical techniques using this open access platform.